Takeda Pharmaceutical Company Limited Share Price
Stocks
4502
JP3463000004
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,286.00 JPY | -2.26% |
|
-7.97% | +9.33% |
| 07-30 | Keros Therapeutics to Receive $20 Million Development Milestone Payment From Takeda | DJ |
| 07-30 | Takeda Pharmaceutical Company Limited, Q1 2027 Earnings Call, Jul 30, 2026 |
| Market Cap | 8,635B 55.08B 47.87B 44.69B 41.03B 77.36B 5,250B 78.71B 527B 206B 2,618B 207B 202B | P/E 2027 * |
43.4x | P/E 2028 * | 26.9x |
|---|---|---|---|---|---|
| Enterprise Value | 12,568B 80.16B 69.67B 65.04B 59.71B 113B 7,641B 115B 767B 300B 3,810B 301B 294B | EV / Sales 2027 * |
2.69x | EV / Sales 2028 * | 2.62x |
| Free-Float |
99.28% | Yield 2027 * |
3.78% | Yield 2028 * | 3.87% |
Last Transcript: Takeda Pharmaceutical Company Limited
| 1 day | -2.26% | ||
| 1 week | -7.97% | ||
| Current month | -4.12% | ||
| 1 month | -4.19% | ||
| 3 months | -0.45% | ||
| 6 months | -3.68% | ||
| Current year | +9.33% |
| 1 week | 5,275 |  | 5,903 |
| 1 month | 5,249 | | 5,903 |
| Current year | 4,710 | | 6,033 |
| 1 year | 4,102 | | 6,033 |
| 3 years | 3,852 | | 6,033 |
| 5 years | 2,993 | | 6,033 |
| 10 years | 2,894.5 | | 6,693 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 23/06/2026 | |
Mikuno Furuta
DFI | Director of Finance/CFO | 48 | 31/03/2024 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 47 | 31/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Plump
BRD | Director/Board Member | 60 | 31/05/2015 |
Steven Gillis
BRD | Director/Board Member | 73 | 31/12/2018 |
Mikuno Furuta
BRD | Director/Board Member | 48 | 31/05/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 10/07/26 | Issuer sale | Director | -1,152 | 0.0001% | ||
| 10/07/26 | Issuer sale | President, Japan Pharma B.U. | -1,022 | 0.0001% | ||
| 10/07/26 | Issuer sale | Director | -1,152 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.26% | -7.97% | +25.29% | +21.69% | 55.08B | |
| -2.39% | -6.36% | +47.10% | +149.66% | 1T | |
| -0.76% | -4.34% | +52.04% | +49.09% | 613B | |
| -2.33% | -4.60% | +25.55% | +64.44% | 433B | |
| +0.20% | -3.07% | +39.84% | +34.54% | 350B | |
| +0.27% | -4.36% | +31.87% | +40.02% | 292B | |
| +2.01% | -9.30% | +5.39% | +7.57% | 239B | |
| +1.77% | -8.05% | -1.47% | -41.90% | 206B | |
| -1.63% | +0.69% | +27.62% | +64.23% | 204B | |
| +0.72% | +0.48% | +15.88% | +73.64% | 163B | |
| Average | +0.16% | -4.12% | +26.91% | +46.30% | 355.56B | |
| Weighted average by Cap. | +0.29% | -4.37% | +34.85% | +70.58% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 4,668B 29.78B 25.88B 24.16B 22.18B 41.82B 2,838B 42.55B 285B 112B 1,415B 112B 109B | 4,747B 30.28B 26.31B 24.57B 22.55B 42.52B 2,886B 43.26B 290B 113B 1,439B 114B 111B |
| Net income | 191B 1.22B 1.06B 986M 906M 1.71B 116B 1.74B 11.63B 4.56B 57.78B 4.57B 4.47B | 316B 2.02B 1.75B 1.64B 1.5B 2.83B 192B 2.88B 19.29B 7.56B 95.84B 7.57B 7.41B |
| Net Debt | 3,932B 25.08B 21.8B 20.35B 18.68B 35.23B 2,391B 35.84B 240B 93.99B 1,192B 94.21B 92.13B | 3,779B 24.1B 20.95B 19.56B 17.95B 33.85B 2,297B 34.44B 231B 90.31B 1,146B 90.53B 88.52B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/08/26 | JP¥5,286.00 | -2.26% | 3,851,800 |
| 03/08/26 | JP¥5,408.00 | -1.90% | 4,750,600 |
| 31/07/26 | JP¥5,513.00 | -3.59% | 7,218,600 |
| 30/07/26 | JP¥5,718.00 | -2.21% | 4,859,800 |
| 29/07/26 | JP¥5,847.00 | +1.79% | 5,289,600 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4502 Stock
Select your edition
All financial news and data tailored to specific country editions
